ZNF334 and colorectal carcinoma: The analysis showed that compared with normal tissues, the expression of ZNF334 was significantly downregulated in stage 1 CRC (p < 0.0001), while no significant differences were found in stage 2, 3 and 4 CRC (p > 0.05) (Fig. 1B).